Top news of the week: 03.11.2021.
Companies And Industries
Engineers devise a way to selectively turn on RNA therapies in human cells
Researchers at MIT and Harvard University have designed a way to selectively turn on gene expression in target cells, including human cells. Their technology can detect specific mRNA ...
mRNA eToehold Tech Could Enable Targeted RNA Therapeutics, Diagnostics, and Cell Sensing
Researchers suggest RNA-based control switch could be used to trigger production of therapeutic proteins to treat cancer or other diseases.
Zaks, fresh from making millions at Moderna, takes venture partner post at OrbiMed
Tal Zaks has revealed his next job. Weeks after leaving Moderna, Zaks has taken up a venture partner post at OrbiMed—where he is joined by another storied biopharma executive.
CRISPR-Chip Inventor Wins Nature Women in Science Award
The award provides the winner $40,000 and aims to celebrate the achievements of women in science and all those who work to support women to stay in STEM careers around the world.
Four more IPOs make strides as a powerful 2021 nears its close
Entrada Therapeutics Inc. is the largest of four biopharmas making new moves on IPOs as the company upsized its offer from 7.5 million to 9.07 million shares priced at $20 each. Last year ...
Democrats circulate a new drug pricing outline with a big carveout for small biotechs
A drug pricing compromise circulating on Capitol Hill and in lobbying circles this week includes a generous carveout for small biotechs.
Researchers: Origins of modern wheat may provide clues to making it stronger
Modern wheat bread may have originated in the Caucuses region of present-day Georgia in eastern Europe, a study published Monday by Nature Biotechnology found.
BioSpace Movers & Shakers, Oct. 29
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.